Cardiac Valve Market Growth And Application By Types (Trans-Catheter Heart Valve, Tissue Heart Valve, And Mechanical Heart Valve, And Others), By Diseases (Aortic Valve Replacement, Heart Valve Disease, Mitral Valve Stenosis, And Others), By Treatment (Valve Replacement, Valve Repair, And Others), And By End Users (Cardiac Research Institute, Hospital & Clinics, And Others) - Europe, Middle East & Africa Forecast Till 2027
Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/610
Market Highlights Human heart is consist of four valve. When blood first enters the heart, it passes through the tricuspid valve and then to the pulmonary valve. After returning from the lungs, the blood passes through the mitral valve and exits via the aortic valve as heart valves are one-way valves.
Furthermore, valve replacement remains the most widely used technique and the proportion of valve repair procedures is increasing in experienced treatment centers. Moreover, developing medical technology and its wide range of applications used in the treatment of various cardiac diseases will fuel the growth of the market over the corresponding period.
However, high cost of the treatment likely to restrain the growth of the market over the assessment period.
The EMEA cardiac valve market is expected to grow at a CAGR of 11.5% during the forecast period 2017-2023.
Major Players in Cardiac Valve Market
Some of the key players in the Europe, the Middle East & Africa market are Medtronic, Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK HealthCare (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil) About Market Research Future:
The EMEA cardiac valve market is expected to grow at a CAGR of 6.5% during the forecasted period.
Regional Analysis
The Europe accounts for the second largest market due to well-developed healthcare sector, continuously increasing patient population, high healthcare expenditure, increasing prevalence of cardiovascular diseases, and rapidly development in the healthcare infrastructure are the major driving factor for the growth of the market. France is the largest cardiac valve market owing to huge patient population and well-developed healthcare sector.
The Middle East & Africa owns the least share of cardiac valve market. However, the Middle East is the major contributor to the market in this region, which is driven by the presence of well-developed economies such as Kuwait and Qatar. On the other hand, due to limited development in the field of medical science and presence of poor countries in Africa, the market is very limited in Africa region.
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Comments